Regulatory controls for 13 drugmakers relaxed by FDA

02/19/2014 | Hill, The

Regulatory controls are being loosened by the FDA for 13 "highly vetted" drugmakers that will get expedited entry for medicines they are importing into the U.S. The firms will assume greater accountability for regulating their own supply chains as part of the Secure Supply Chain Pilot Program, allowing the FDA to concentrate on stopping adulterated, misbranded and unapproved medicines from entering the country. "We're still going to be looking at them, but we have a greater degree of confidence that their drugs are not going to need to be as thoroughly vetted as others," said FDA spokesman Christopher Kelly.

View Full Article in:

Hill, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA